カテゴリ： MarketLine, 企業調査, 日本

Shionogi & Co., Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6910
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Shionogi & Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Shionogi & Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Shionogi & Co., Ltd. (Shionogi or ‘the group’) is engaged in the research, development, manufacture, and marketing of ethical drugs, over-the-counter (OTC) drugs and diagnostic products. The company offers its products under its brands: Crestor, Irbetan, AIMIX, IRTRA, Cymbalta, Pirespa, Differin, Rapiacta, Finibax, OxyContin, OxiNorm, OxiFast, Sedes, Correct Series, opon Series, Brightpoc Flu, Allerport TARC and HISCL-TARC. It operates in Japan, Europe, North America and other regions of the world. Shionogi is headquartered in Osaka, Japan.

Scope

- Detailed information on Shionogi & Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Shionogi & Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Shionogi & Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Shionogi & Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Shionogi & Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Shionogi & Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Shionogi & Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Shionogi & Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Shionogi & Co., Ltd.: Company Overview 9
Shionogi & Co., Ltd.: Overview and Key Facts 9
Shionogi & Co., Ltd.: Overview 9
Shionogi & Co., Ltd.: Key Facts 9
Shionogi & Co., Ltd.: Key Employees 11
Shionogi & Co., Ltd.: Key Employee Biographies 13
Shionogi & Co., Ltd.: Major Products and Services 15
Shionogi & Co., Ltd.: Company History 16
Shionogi & Co., Ltd.: Management Statement 22
Shionogi & Co., Ltd.: Locations and Subsidiaries 23
Shionogi & Co., Ltd.: Key Competitors 24
Shionogi & Co., Ltd.: Company Analysis 25
Shionogi & Co., Ltd.: Business Description 25
Shionogi & Co., Ltd.: SWOT Analysis 26
Shionogi & Co., Ltd.: SWOT Overview 26
Shionogi & Co., Ltd.: Strengths 26
Shionogi & Co., Ltd.: Weaknesses 27
Shionogi & Co., Ltd.: Opportunities 27
Shionogi & Co., Ltd.: Threats 29
Shionogi & Co., Ltd.: Corporate Financial Deals Activity 30
Shionogi & Co., Ltd.: Financial Deals Overview 30
Shionogi & Co., Ltd.: Targets and Partners 32
Shionogi & Co., Ltd.: Top Deals 2014 – 2018YTD* 34
Shionogi & Co., Ltd.: Corporate Venturing 35
Shionogi & Co., Ltd.: Partnership 36
Shionogi & Co., Ltd.: Divestments 37
Shionogi & Co., Ltd.: Recent Developments 38
Shionogi & Co., Ltd.: News and Events Summary 38
Shionogi & Co., Ltd.: Business Expansion 41
Shionogi & Co., Ltd.: Contracts 42
Shionogi & Co., Ltd.: Financial Deals 42
Shionogi & Co., Ltd.: Financial Performance 43
Shionogi & Co., Ltd.: Regulatory and Legal Events 44
Shionogi & Co., Ltd.: Research & Development 44
Shionogi & Co., Ltd.: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Shionogi & Co., Ltd.: Key Facts
Table 2: Shionogi & Co., Ltd.: Key Employees
Table 3: Shionogi & Co., Ltd.: Company History
Table 4: Shionogi & Co., Ltd.: Locations and Subsidiaries
Table 5: Shionogi & Co., Ltd.: Key Competitors
Table 6: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Shionogi & Co., Ltd.: Targets and Partners
Table 9: Shionogi & Co., Ltd.: Top Deals 2014 - 2018YTD*
Table 10: Shionogi & Co., Ltd.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 11: Shionogi & Co., Ltd.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 12: Shionogi & Co., Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Shionogi & Co., Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Shionogi & Co., Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Shionogi & Co., Ltd.: News and Events Summary
Table 16: Shionogi & Co., Ltd.: Business Expansion
Table 17: Shionogi & Co., Ltd.: Contracts
Table 18: Shionogi & Co., Ltd.: Financial Deals
Table 19: Shionogi & Co., Ltd.: Financial Performance
Table 20: Shionogi & Co., Ltd.: Regulatory and Legal Events
Table 21: Shionogi & Co., Ltd.: Research & Development
Table 22: Shionogi & Co., Ltd.: Strategy and Operations

List of Figures
Figure 1: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Shionogi & Co., Ltd.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: Shionogi & Co., Ltd.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: Shionogi & Co., Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Shionogi & Co., Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 7: Shionogi & Co., Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Shionogi & Co., Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Empire District Electric Company：発電所・企業SWOT分析
    The Empire District Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Abbott Laboratories (ABT)：企業の財務・戦略的SWOT分析
    Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Applied Materials, Inc.：企業の戦略・SWOT・財務情報
    Applied Materials, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Materials, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Karambunai Corporation Berhad：企業の戦略・SWOT・財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kaken Pharmaceutical Co Ltd (4521)：製薬・医療：M&Aディール及び事業提携情報
    Summary Kaken Pharmaceutical Co Ltd (Kaken Pharma) is a pharmaceutical company that conducts research and develops drugs, agrochemicals, medical equipment and animal health products. The company offers solutions in the fields of orthopedics, dermatology, immunology, inflammation, allergies, fungal i …
  • Advanced Accelerator Applications SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Wind Direct Ltd：電力：M&Aディール及び事業提携情報
    Summary Wind Direct Ltd (Wind Direct) a subsidiary of Infinite Renewables Ltd is a renewable energy company that installs and operates industrial wind turbines. The company’s services include feasibility studies, wind turbine installation, and operation services. It offers consulting services to che …
  • Applied Materials Inc (AMAT)：企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Peet’s Coffee & Tea Inc：企業の戦略・SWOT・財務情報
    Peet's Coffee & Tea Inc - Strategy, SWOT and Corporate Finance Report Summary Peet's Coffee & Tea Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ARxIUM：医療機器：M&Aディール及び事業提携情報
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • Enterprise Products Partners LP (EPD)：石油・ガス：M&Aディール及び事業提携情報
    Summary Enterprise Products Partners LP (Enterprise Products) is a provider of midstream energy services. The company‘s services include natural gas gathering, treating, processing, transportation and storage; transportation of natural gas liquids (NGL), fractionation, storage, and import and export …
  • Bartlett Holdings Inc：電力：M&Aディール及び事業提携情報
    Summary Bartlett Holdings Inc, doing business as BHI Energy, a subsidiary of AE Industrial Partners LLC, is a specialty service and staffing solutions provider. The company offers complete maintenance, radiological and professional technical staffing solutions. It provides power services including m …
  • MetGen Oy-製薬・医療分野：企業M&A・提携分析
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company provides metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosi …
  • PT Adaro Energy Tbk：企業の戦略・SWOT・財務情報
    PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Challenge Group Holdings PTE. LTD.：企業の戦略・SWOT・財務情報
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Aarti Drugs Ltd (AARTIDRUGS)：企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical in …
  • MEDITE Cancer Diagnostics Inc (MDIT)：医療機器：M&Aディール及び事業提携情報
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • Jabil Inc (JBL)-エネルギー分野：企業M&A・提携分析
    Summary Jabil Inc (Jabil) is a provider of electronic manufacturing services and solutions. It offers electronics design, production and product management services. Its service portfolio includes component selection, sourcing and procurement, integrated design and engineering, enclosure services an …
  • Obuv Rossii OOO (OBUV)：企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Oil States International, Inc.：企業の戦略・SWOT・財務情報
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆